Division of Cardiovascular Medicine

October 5, 2023

Study finds no difference in heart transplant outcomes using organs donated after circulatory death and after brain death

A Vanderbilt study found no difference in one-year survival and other outcomes among heart transplant patients who received their new organs from from donation after circulatory death and donation after brain death.

By Matt Batcheldor
ELVIS team leaders include, from left, Jane Freedman, MD, project leader Suman Das, PhD, Simon Mallal, MBBS, Ravi Shah, MD, John McLean, PhD. (photo by Erin O. Smith)
September 19, 2023

$51 million NIH grant brings ELVIS to VUMC

Vanderbilt University Medical Center scientists are launching a research platform called ELVIS that is devoted to molecular underpinnings of early-childhood determinants of health.

By Paul Govern
June 1, 2023

Vanderbilt Patient-Reported Outcomes Measurement System collects millionth report

The Vanderbilt Patient-Reported Outcomes Measurement System has collected its millionth patient-reported outcome measure (PROM), or pre-appointment survey that patients complete about their health, making it one of the largest collections of such surveys in the United States.

By Jill Clendening
March 6, 2023

Cell-free hemoglobin in pulmonary hypertension

Cell-free hemoglobin generated by the lungs may be a therapeutic target for treating pulmonary arterial hypertension, Vanderbilt researchers found.

By Leigh MacMillan
February 23, 2023

2022 another strong year for Vanderbilt Transplant Center

By Matt Batcheldor
February 23, 2023

Study sheds new light on hormone therapy as menopause treatment

Vanderbilt research shows that hormone replacement therapy can be safely administered depending on the method used and the patient’s age, time since menopause, and risk of cardiovascular disease.

By Matt Batcheldor
February 7, 2023

A new view of a cholesterol carrier

Vanderbilt researchers developed a novel method to measure small RNAs carried by HDL and demonstrated that these molecules circulate in greater concentrations than previously believed and are likely to contribute to communication between immune cells.
By Kelsey Pinckard 
January 25, 2023

Study finds heart failure risk higher in rural areas

A study co-led by Vanderbilt researchers found heart failure risk is 19% higher for adults living in rural areas of the U.S., as compared to urban areas, and 34% higher for Black men living in rural areas.
By Craig Boerner
January 19, 2023

Study points to new ways to prevent, treat heart disease

Vanderbilt researchers have confirmed the existence of an alternative pathway to atherosclerosis, a finding that may lead to new ways to prevent and treat cardiovascular disease.
By Bill Snyder
November 10, 2022

Study explores CVD risk for people with HIV

A Vanderbilt study found that among people with HIV infection, three types of CD4+ T helper cells are associated with incident cardiovascular disease (CVD) that are not explained by CVD risk.
By Matt Batcheldor
October 10, 2022

Counting steps can reduce disease risk: study

A Vanderbilt study found that using a wearable activity tracker to count and increase the number and intensity of steps taken daily can reduce the risk of several common, chronic diseases.
By Bill Snyder
September 29, 2022

Suzie Brown, singer-songwriter, meet Dr. Suzanne Brown Sacks, transplant cardiologist

Her twin passions for music and for medicine brought her to Nashville and to VUMC
By Matt Batcheldor
September 29, 2022

Study shows CMS reimbursement not associated with wider EPD use

Vanderbilt research shows that higher reimbursement from the Centers for Medicare & Medicaid Services was not associated with wider use of an embolic protection device during transcatheter aortic valve replacement procedures.
By Matt Batcheldor